tryparsamide

first stage of the disease. By 1922, Suramin was generally combined with tryparsamide (another pentavalent organoarsenic drug), the first drug to enter the

Truxcillin truxicurium iodide (INN) truxipicurium iodide (INN) Trymex tryparsamide (INN) Tryptacin Trysul Tryvio tuaminoheptane (INN) Tubersol tubocurarine

missionary Dr. Arthur Lewis Piper was the first person to use and bring tryparsamide, the Rockefeller Foundation's drug to cure sleeping sickness, to the

protocol for human trials to establish tryparsamide's safety, effectiveness, and optimum dosage. Tryparsamide proved successful in combating the fatal

patients. Drug advances for sleeping sickness included Germanin and tryparsamide [de; fi; it]. Trensz conducted experiments showing that the non-amoebic